Getting started

Talk to your doctor to choose the dosing regimen that works best for you.

For the first 4 weeks of treatment, you will take a loading dose once per week. This will increase the levels of HEMLIBRA in your blood. When the loading dose is complete, you will start taking a maintenance dose, which can be:

How should I take HEMLIBRA?

A change in medication can mean a change in your routine

If your healthcare provider feels it’s appropriate for you, HEMLIBRA may be self-injected after training. You should not inject HEMLIBRA without proper training by your healthcare provider.

As you prepare to start your treatment journey, carefully review the detailed "Instructions for Use" information provided by your treatment centre. This contains information on how to:

  • Use HEMLIBRA exactly as prescribed by your healthcare provider.
  • Stop (discontinue) prophylactic use of bypassing agents the day before starting HEMLIBRA prophylaxis.
  • You may continue prophylactic use of FVIII for the first week of HEMLIBRA prophylaxis.
  • HEMLIBRA is given as an injection under your skin (subcutaneous injection) by you or a caregiver.
  • Your healthcare provider should show you or your caregiver how to prepare, measure, and inject your dose of HEMLIBRA before you inject yourself for the first time.
  • Do not attempt to inject yourself or another person unless you have been taught how to do so by a healthcare provider.

Learn how to prepare and inject HEMLIBRA

Your healthcare provider will train you or your caregiver on how to inject. Once trained, you should be able to inject HEMLIBRA at home by yourself or with the help of a caregiver. Talk to your healthcare provider if you have any questions.

Watch the injection video

See a demonstration of how to use a transfer needle to prepare and inject HEMLIBRA. For more information, please refer to the Instructions for Use, or contact your healthcare provider.



This material is for viewing by New Zealand audiences only

Link to Third Party Site

You are about to leave the site to one that is not controlled or developed by Roche Products (New Zealand) Ltd.

Roche does not endorse or control the content of any linked websites and if you click OK, you agree that Roche has no responsibility or duty to you for anything that happens to you as a result. If the linked site is outside New Zealand’s jurisdiction, the information may not be consistent with New Zealand’s legislation, advertising codes or the relevant New Zealand registered Data Sheet. Please refer to the Data Sheet or Consumer Medicine Information on the Medsafe website for product information applicable to New Zealand.

Click OK to continue.

Cancel OK